Emergent Net Debt from 2010 to 2025

EBS Stock

USD 11.11 0.31 2.87%

Emergent Biosolutions Net Debt yearly trend continues to be comparatively stable with very little volatility. Net Debt is likely to outpace its year average in 2025. Net Debt is the total debt of Emergent Biosolutions minus its cash and cash equivalents. It represents the actual debt burden on the company after accounting for the liquid assets it holds. View All Fundamentals

Net Debt

First Reported

2004-12-31

Previous Quarter

805.8 M

Current Value

-149.1 M

Quarterly Volatility

327.3 M

Housing Crash

Credit Downgrade

Yuan Drop

Covid

Check Emergent Biosolutions financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Emergent Biosolutions' main balance sheet or income statement drivers, such as Depreciation And Amortization of 151.1 M, Interest Expense of 106.1 M or Total Revenue of 1.3 B, as well as many indicators such as Price To Sales Ratio of 0.13, Dividend Yield of 0.018 or PTB Ratio of 0.21. Emergent financial statements analysis is a perfect complement when working with Emergent Biosolutions Valuation or Volatility modules.

Check out the analysis of Emergent Biosolutions Correlation against competitors.

For more information on how to buy Emergent Stock please use our How to Invest in Emergent Biosolutions guide.

Latest Emergent Biosolutions' Net Debt Growth Pattern

Below is the plot of the Net Debt of Emergent Biosolutions over the last few years. It is the total debt of a company minus its cash and cash equivalents. It represents the actual debt burden on the company after accounting for the liquid assets it holds. Emergent Biosolutions' Net Debt historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Emergent Biosolutions' overall financial position and show how it may be relating to other accounts over time.

Net Debt

10 Years Trend

Slightly volatile

Compare to Others All Fundamentals

Net Debt

Timeline

Emergent Net Debt Regression Statistics

	Arithmetic Mean	288,144,359
	Coefficient Of Variation	140.14
	Mean Deviation	359,165,324
	Median	253,500,000
	Standard Deviation	403,801,373
	Sample Variance	163055.5T
	Range	1.1B
	R-Value	0.85
	Mean Square Error	49281.4T
	R-Squared	0.72
	Significance	0.000034
	Slope	71,863,700
	Total Sum of Squares	2445833.2T

Emergent Net Debt History

	2025	903.8 M
	2024	860.8 M
	2023	748.5 M
	2022	763.2 M
	2021	264.9 M
	2020	253.5 M
	2019	643.5 M

Other Fundumenentals of Emergent Biosolutions

Net Debt To E B I T D A

Emergent Biosolutions Net Debt component correlations

	Total Assets	Total Stockholder Equity	Net Debt	Retained Earnings	Accounts Payable	Net Receivables	Good Will	Total Liab	Total Current Assets	Short Term Debt	Intangible Assets	Common Stock	Current Deferred Revenue	Long Term Debt	Short Term Investments	Property Plant Equipment	Deferred Long Term Liab	Treasury Stock	Net Tangible Assets	Long Term Debt Total	Capital Surpluse	Short Long Term Debt	Cash And Equivalents	Net Invested Capital	Net Working Capital	Capital Stock
Total Assets		0.93	0.62	0.42	0.54	0.63	0.67	0.9	0.64	0.43	0.71	0.7	0.7	0.88	0.79	0.73	0.77	-0.58	0.88	0.85	0.86	0.14	0.58	0.89	0.15	0.02
Total Stockholder Equity	0.93		0.37	0.52	0.35	0.52	0.45	0.74	0.54	0.23	0.49	0.48	0.74	0.79	0.61	0.61	0.63	-0.4	0.77	0.76	0.71	-0.05	0.41	0.81	0.37	0.11
Net Debt	0.62	0.37		-0.19	0.7	0.52	0.71	0.88	0.36	0.69	0.75	0.72	0.26	0.61	0.91	0.84	0.82	-0.81	0.73	0.68	0.81	0.46	0.51	0.74	-0.49	-0.55
Retained Earnings	0.42	0.52	-0.19		0.29	0.44	0.38	0.17	0.75	-0.12	0.38	0.34	0.59	0.35	0.06	-0.12	0.06	0.13	0.2	0.3	0.08	-0.16	0.08	0.41	0.65	0.48
Accounts Payable	0.54	0.35	0.7	0.29		0.71	0.88	0.72	0.79	0.43	0.83	0.86	0.6	0.56	0.81	0.64	0.67	-0.64	0.73	0.64	0.69	0.24	0.63	0.72	-0.04	-0.43
Net Receivables	0.63	0.52	0.52	0.44	0.71		0.89	0.59	0.7	0.01	0.85	0.87	0.68	0.77	0.67	0.39	0.52	-0.29	0.67	0.76	0.65	-0.28	0.23	0.58	0.3	0.03
Good Will	0.67	0.45	0.71	0.38	0.88	0.89		0.74	0.79	0.31	0.98	0.98	0.6	0.74	0.8	0.51	0.65	-0.49	0.73	0.76	0.73	0.08	0.45	0.7	0.03	-0.11
Total Liab	0.9	0.74	0.88	0.17	0.72	0.59	0.74		0.59	0.63	0.78	0.75	0.58	0.82	0.94	0.89	0.89	-0.77	0.89	0.86	0.89	0.35	0.64	0.95	-0.15	-0.36
Total Current Assets	0.64	0.54	0.36	0.75	0.79	0.7	0.79	0.59		0.33	0.76	0.79	0.67	0.55	0.53	0.38	0.47	-0.42	0.65	0.55	0.56	0.16	0.57	0.69	0.24	0.07
Short Term Debt	0.43	0.23	0.69	-0.12	0.43	0.01	0.31	0.63	0.33		0.38	0.39	-0.08	0.1	0.54	0.69	0.51	-0.85	0.52	0.16	0.58	0.91	0.65	0.59	-0.74	-0.44
Intangible Assets	0.71	0.49	0.75	0.38	0.83	0.85	0.98	0.78	0.76	0.38		0.97	0.55	0.75	0.82	0.53	0.68	-0.52	0.72	0.76	0.74	0.16	0.42	0.75	-0.02	-0.1
Common Stock	0.7	0.48	0.72	0.34	0.86	0.87	0.98	0.75	0.79	0.39	0.97		0.57	0.72	0.81	0.57	0.66	-0.58	0.8	0.71	0.8	0.15	0.55	0.71	-0.03	-0.08
Current Deferred Revenue	0.7	0.74	0.26	0.59	0.6	0.68	0.6	0.58	0.67	-0.08	0.55	0.57		0.77	0.57	0.43	0.52	-0.22	0.67	0.77	0.55	-0.3	0.4	0.67	0.62	0.04
Long Term Debt	0.88	0.79	0.61	0.35	0.56	0.77	0.74	0.82	0.55	0.1	0.75	0.72	0.77		0.78	0.6	0.75	-0.36	0.76	0.98	0.73	-0.18	0.37	0.77	0.33	0.0
Short Term Investments	0.79	0.61	0.91	0.06	0.81	0.67	0.8	0.94	0.53	0.54	0.82	0.81	0.57	0.78		0.87	0.87	-0.77	0.88	0.84	0.9	0.26	0.59	0.88	-0.16	-0.45
Property Plant Equipment	0.73	0.61	0.84	-0.12	0.64	0.39	0.51	0.89	0.38	0.69	0.53	0.57	0.43	0.6	0.87		0.88	-0.9	0.88	0.67	0.9	0.4	0.72	0.8	-0.31	-0.58
Deferred Long Term Liab	0.77	0.63	0.82	0.06	0.67	0.52	0.65	0.89	0.47	0.51	0.68	0.66	0.52	0.75	0.87	0.88		-0.77	0.82	0.8	0.85	0.25	0.56	0.81	-0.13	-0.43
Treasury Stock	-0.58	-0.4	-0.81	0.13	-0.64	-0.29	-0.49	-0.77	-0.42	-0.85	-0.52	-0.58	-0.22	-0.36	-0.77	-0.9	-0.77		-0.79	-0.42	-0.82	-0.65	-0.78	-0.7	0.53	0.5
Net Tangible Assets	0.88	0.77	0.73	0.2	0.73	0.67	0.73	0.89	0.65	0.52	0.72	0.8	0.67	0.76	0.88	0.88	0.82	-0.79		0.77	0.98	0.19	0.75	0.84	-0.02	-0.24
Long Term Debt Total	0.85	0.76	0.68	0.3	0.64	0.76	0.76	0.86	0.55	0.16	0.76	0.71	0.77	0.98	0.84	0.67	0.8	-0.42	0.77		0.74	-0.13	0.37	0.81	0.27	-0.16
Capital Surpluse	0.86	0.71	0.81	0.08	0.69	0.65	0.73	0.89	0.56	0.58	0.74	0.8	0.55	0.73	0.9	0.9	0.85	-0.82	0.98	0.74		0.25	0.69	0.81	-0.17	-0.29
Short Long Term Debt	0.14	-0.05	0.46	-0.16	0.24	-0.28	0.08	0.35	0.16	0.91	0.16	0.15	-0.3	-0.18	0.26	0.4	0.25	-0.65	0.19	-0.13	0.25		0.54	0.33	-0.77	-0.35
Cash And Equivalents	0.58	0.41	0.51	0.08	0.63	0.23	0.45	0.64	0.57	0.65	0.42	0.55	0.4	0.37	0.59	0.72	0.56	-0.78	0.75	0.37	0.69	0.54		0.61	-0.21	-0.26
Net Invested Capital	0.89	0.81	0.74	0.41	0.72	0.58	0.7	0.95	0.69	0.59	0.75	0.71	0.67	0.77	0.88	0.8	0.81	-0.7	0.84	0.81	0.81	0.33	0.61		0.02	-0.28
Net Working Capital	0.15	0.37	-0.49	0.65	-0.04	0.3	0.03	-0.15	0.24	-0.74	-0.02	-0.03	0.62	0.33	-0.16	-0.31	-0.13	0.53	-0.02	0.27	-0.17	-0.77	-0.21	0.02		0.48
Capital Stock	0.02	0.11	-0.55	0.48	-0.43	0.03	-0.11	-0.36	0.07	-0.44	-0.1	-0.08	0.04	0.0	-0.45	-0.58	-0.43	0.5	-0.24	-0.16	-0.29	-0.35	-0.26	-0.28	0.48

Click cells to compare fundamentals

About Emergent Biosolutions Financial Statements

Emergent Biosolutions shareholders use historical fundamental indicators, such as Net Debt, to determine how well the company is positioned to perform in the future. Although Emergent Biosolutions investors may analyze each financial statement separately, they are all interrelated. The changes in Emergent Biosolutions' assets and liabilities, for example, are also reflected in the revenues and expenses on on Emergent Biosolutions' income statement. Understanding these patterns can help investors time the market effectively. Please read more on our fundamental analysis page.

	Last Reported	Projected for Next Year
Net Debt	860.8 M	903.8 M
Net Debt To EBITDA	(1.70)	(1.79)

Thematic Opportunities

Explore Investment Opportunities

Build portfolios using Macroaxis predefined set of investing ideas. Many of Macroaxis investing ideas can easily outperform a given market. Ideas can also be optimized per your risk profile before portfolio origination is invoked. Macroaxis thematic optimization helps investors identify companies most likely to benefit from changes or shifts in various micro-economic or local macro-level trends. Originating optimal thematic portfolios involves aligning investors' personal views, ideas, and beliefs with their actual investments.

Explore Investing Ideas

Additional Tools for Emergent Stock Analysis

When running Emergent Biosolutions' price analysis, check to measure Emergent Biosolutions' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Emergent Biosolutions is operating at the current time. Most of Emergent Biosolutions' value examination focuses on studying past and present price action to predict the probability of Emergent Biosolutions' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Emergent Biosolutions' price. Additionally, you may evaluate how the addition of Emergent Biosolutions to your portfolios can decrease your overall portfolio volatility.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC

Emergent Net Debt from 2010 to 2025

Latest Emergent Biosolutions' Net Debt Growth Pattern

Emergent Net Debt Regression Statistics

Emergent Net Debt History

Other Fundumenentals of Emergent Biosolutions

Emergent Biosolutions Net Debt component correlations

About Emergent Biosolutions Financial Statements

Thematic Opportunities

Explore Investment Opportunities

Additional Tools for Emergent Stock Analysis

COMMON DESTINATIONS

MAIN CATEGORIES

COMPANY